Glaxo OTC weight drug is effective -FDA panel
Posted on: Monday, 23 January 2006, 16:30 CST
BETHESDA, Maryland (Reuters) - GlaxoSmithKline's low-dose version of Xenical is effective in helping people lose weight when used without a prescription for six months, a U.S. advisory panel said unanimously on Monday.
The U.S. Food and Drug Administration panel of outside advisers is weighing whether the drug should be approved for over-the-counter sales.
Some members of the panel, which must still consider whether the drug is safe, expressed concern about whether the nonprescription version would be effective long-term.
Source: REUTERS
Related Articles
- Atlanta Defensive Driving and DUI School Completes Expansion to Meet Growing Demand
- Teen Drug Testing Curbs Rate of Addiction, Says Project 7th Grade
- Only 6 Percent of Parents Worried About Teen RX Drug Abuse
- Panel: Drug Shouldn't Be Used for ADHD Yet
- All American Research and Drug Testing Launches Drug Screening Product
- The Expected Toxicity Rate at the Maximum Tolerated Dose in Bridging Studies in Alzheimer's Disease
- FDA Panel to Review Cancer Drug
- Two Drug Makers Spar With FDA Panel Over Safety of Arthritis Medicines
- FDA Panel to Consider Over-the-Counter Status of Cholesterol-Lowering Drug
- New Drug Panel Needed
Rating: 3.2 / 5 (11 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds